(Q30788063)

26 June 2017

Prolonged in vivo residence times of llama single-domain antibody fragments in pigs by binding to porcine immunoglobulins (English)

1 reference

26 June 2017

1 reference

Michiel M Harmsen

1

1 reference

26 June 2017

Conny B Van Solt

series ordinal

2

1 reference

26 June 2017

Helmi P D Fijten

series ordinal

3

1 reference

26 June 2017

Marga C Van Setten

series ordinal

4

1 reference

26 June 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

26 June 2017

1 reference

26 June 2017

23

1 reference

26 June 2017

41

1 reference

26 June 2017

4926-4934

1 reference

Pharmacokinetics and biodistribution of genetically engineered antibodies

26 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.017

A Theoretical Model of γ-Globulin Catabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.017

Finally! The Brambell receptor (FcRB). Mediator of transmission of immunity and protection from catabolism for IgG.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.017

Adapting pharmacokinetic properties of a humanized anti-interleukin-8 antibody for therapeutic applications using site-specific pegylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.017

Therapeutic antibody fragments with prolonged in vivo half-lives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.017

Prolonged in vivo residence times of antibody fragments associated with albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.017

Expression of single-chain Fv-Fc fusions in Pichia pastoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.017

Retargeting serum immunoglobulin with bispecific diabodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.017

Comparison of physical chemical properties of llama VHH antibody fragments and mouse monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.017

Isolation of antigen specific llama VHH antibody fragments and their high level secretion by Saccharomyces cerevisiae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.017

Camel single-domain antibodies as modular building units in bispecific and bivalent antibody constructs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.017

Comparison of llama VH sequences from conventional and heavy chain antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.017

Llama heavy-chain V regions consist of at least four distinct subfamilies revealing novel sequence features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.017

Monoclonal antibodies against porcine immunoglobulin isotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.017

Antibody repertoire development in fetal and neonatal piglets. V. VDJ gene chimeras resembling gene conversion products are generated at high frequency by PCR in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.017

Effect of altered CH2-associated carbohydrate structure on the functional properties and in vivo fate of chimeric mouse-human immunoglobulin G1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.017

Efficient tumor targeting by single-domain antibody fragments of camels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.017

Expression of a bispecific dsFv–dsFv′ antibody fragment in Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.017

Design and application of diabodies, triabodies and tetrabodies for cancer targeting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.017

Cloning and expression of a single-chain antibody fragment specific for foot-and-mouth disease virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.017

Generation and applications of monoclonal antibodies for livestock production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.017

Emergency vaccination of pigs against foot-and-mouth disease: protection against disease and reduction in contact transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.017

The biological relevance of virus neutralisation sites for virulence and vaccine protection in the guinea pig model of foot-and-mouth disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.017

History of the control of foot and mouth disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.017

Epitope analysis of the F4 (K88) fimbrial antigen complex of enterotoxigenic Escherichia coli by using monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.017

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2005.05.017

1 reference

26 June 2017

1 reference